Cambia (Royalty Interest) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Cambia (Royalty Interest) General Information
Description
A pharmaceutical product indicated for the treatment of migraine. The drug provides migraine pain relief in 2 hours with effects starting within 15 minutes from consumption.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- United States
Cambia (Royalty Interest) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|